Pacmed and the department of Medical Informatics of the AmsterdamUMC and University of Amsterdam have received a grant under the Kansen Voor West III program, funded by the European Fund for Regional Development (EFRD) of the European Union, to do research on causal inference.
Intensive care physicians could gain much more value from AI decision support when not only the risk of an undesirable outcome is predicted, but when it helps to determine the best intervention trajectory (by predicting the effects of, for example, letting a patient stay an extra day on the ICU). This requires treatment effect estimation. Techniques to estimate treatment effects come from the domain of causal inference, also referred to as causal AI.
Pacmed's collaboration with AmsterdamUMC, the Santeon hospitals and healthcare insurers such as CZ and Zilveren Kruis, will enable the validation and application of this new type of technology in practice. The project started in 2022 and will run for at least 3 years.
.jpg)
